 Kieuhoa Vo, MD
|
| Title | Assistant Professor |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Pediatrics |
|---|
| Address | 550 16th. Street
San Francisco CA 94158
|
|---|
| Phone | 415-476-3831 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of Notre Dame | B.S., Biological Sciences | 2004 | | | Indiana University School of Medicine | M.D. | 2008 | | | Nationwide Children's Hospital | Pediatric Residency | 2011 | | | University of California, San Francisco | M.A.S., Clinical Research | 2015 | | | University of California, San Francisco | Pediatric Oncology/Hematology Fellowship | 2015 | |
ORNG Applications Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Vo K, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2016 Oct 25. PMID: 27793021.
-
Huibregtse KE, Vo K, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK, et al. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 Aug 26; 66:144-152. PMID: 27573428.
-
Vo K, Matthay KK, DuBois SG. Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9. PMID: 27274393.
-
Davenport JR, Vo K, Goldsby R, West DC, DuBois SG. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5. PMID: 26891183.
-
Vo K, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Jul 15; 22(14):3643-50. PMID: 26861456.
-
Thompson D, Vo K, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45. PMID: 26709890.
-
Vo K, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 1; 32(28):3169-76. PMID: 25154816; PMCID: PMC4171360.
-
Vo K, Grooms L, Klima J, Holland-Hall C, O'Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5. PMID: 23005346.
-
Joo J, Christensen L, Warner K, States L, Kang HG, Vo K, Lawlor ER, May WA. GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS One. 2009; 4(10):e7608. PMID: 19859563; PMCID: PMC2763206.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|
